Management of Hepatitis B Vaccine Non‑Responders

Initial Revaccination Strategy

• Non‑responders should receive a full second three‑dose hepatitis B vaccine series (0, 1, 6 months) followed by anti‑HBs testing 1–2 months after the final dose. 1
• Between 44 % and 100 % of individuals who failed the primary series achieve protective anti‑HBs (≥10 mIU/mL) after this complete second series. 2

Pre‑Revaccination Testing

• Prior to revaccination, test for HBsAg to exclude chronic HBV infection, especially in persons with known risk factors (household contacts of HBsAg‑positive individuals, injection drug users, men who have sex with men, or those born in endemic regions). 1
• Do not postpone the first revaccination dose while awaiting HBsAg results; the dose can be administered immediately after blood collection. 1

Standard Revaccination Protocol – Immunocompetent Adults

• Administer three standard‑dose (20 µg) hepatitis B vaccine injections at 0, 1, 6 months. 1
• If the schedule is interrupted, continue with the next dose without restarting the series, ensuring at least an 8‑week interval between the second and third doses. 1
• Measure anti‑HBs 1–2 months after the final dose to document serologic response. [1][3]

Post‑Revaccination Management – Immunocompetent Individuals

• When anti‑HBs ≥10 mIU/mL is confirmed after revaccination, no further routine testing or booster doses are required; long‑term protection is maintained through immune memory. [1][3]

Management of Confirmed Non‑Responders

• If anti‑HBs remains <10 mIU/mL after two complete vaccine series, the individual is classified as a confirmed non‑responder. [4][3]
• Such patients should be counseled that they remain susceptible to HBV infection. 4
• Following occupational or accidental exposure to HBV‑positive blood or body fluids, administer two doses of hepatitis B immune globulin (0.06 mL/kg): the first as soon as possible and the second one month later. 4

Special Considerations – Immunocompromised Patients

• Perform annual anti‑HBs testing for HIV‑infected persons, hematopoietic stem‑cell transplant recipients, and patients receiving chemotherapy. [1][2]
• Provide booster vaccine doses whenever anti‑HBs falls below 10 mIU/mL. [1][2]
• Immunocompromised individuals cannot rely on immune memory alone and require maintained circulating antibody levels for protection. 1

Healthcare‑Worker Specific Guidance

• For healthcare workers who completed the primary series but have anti‑HBs <10 mIU/mL, give one additional vaccine dose immediately and re‑test anti‑HBs 1–2 months later. 1
• If anti‑HBs remains <10 mIU/mL after this single dose, complete the full second series (resulting in a total of six doses when combined with the original series). [1][4]
• This staged approach is practical for recently vaccinated healthcare workers. 1
• Document vaccine‑response status to guide future occupational exposure management. [4][3]

Documentation and Record‑Keeping

• Keep written, dated records of every vaccine dose administered and all serologic test results. 3

Common Pitfalls to Avoid

• Do not interpret low anti‑HBs levels measured years after childhood vaccination as non‑response; waning antibodies are expected in individuals who retain immune memory. 3
• Do not restart the vaccine series if doses are delayed; simply continue with the next scheduled dose respecting minimum intervals. 1

Management of Patients with No Immunity to Hepatitis B

Initial Assessment and Revaccination Protocol

• The Centers for Disease Control and Prevention recommends that patients with no immunity to hepatitis B (anti-HBs <10 mIU/mL) receive a complete revaccination series with three doses of hepatitis B vaccine at 0, 1, and 6 months, followed by anti-HBs testing 1-2 months after the final dose 5
• Before proceeding with revaccination, test for HBsAg to rule out chronic HBV infection, particularly if the patient has risk factors for HBV exposure, as recommended by the Centers for Disease Control and Prevention 6

Standard Revaccination Approach

• The Centers for Disease Control and Prevention recommends administering a complete 3-dose vaccine series at 0, 1, and 6 months 5
• Most non-responders (44-100%) will develop protective antibody levels after receiving this second complete vaccination series, according to the Centers for Disease Control and Prevention 5
• Do not restart the series if interrupted—simply continue with the next dose when able, as recommended by the Centers for Disease Control and Prevention 7

Post-Revaccination Testing

• Test anti-HBs levels 1-2 months after the final vaccine dose to confirm adequate response (≥10 mIU/mL), as recommended by the Centers for Disease Control and Prevention 5
• This timing is critical to accurately assess vaccine-induced immunity, according to the Centers for Disease Control and Prevention 6

Management Based on Patient Category

• If the patient is a healthcare worker who previously completed a full vaccine series but now has anti-HBs <10 mIU/mL, give one additional vaccine dose immediately, followed by anti-HBs testing 1-2 months later, as recommended by the Centers for Disease Control and Prevention 7, 6

Special Considerations and Pitfalls

• Do not delay revaccination while waiting for additional testing or risk stratification, as recommended by the Centers for Disease Control and Prevention 8
• Do not restart the vaccine series if doses are delayed—simply continue from where you left off, according to the Centers for Disease Control and Prevention 7

Documentation and Follow-Up

• Maintain written documentation of all vaccine doses and serologic test results, as recommended by the Centers for Disease Control and Prevention 9, 10
• Schedule the 1-2 month post-vaccination testing appointment at the time of the final vaccine dose to ensure compliance, according to the Centers for Disease Control and Prevention 5